Literature DB >> 12650742

Plasma levels of soluble transferrin receptors and Clara cell protein (CC16) during bipolar mania and subsequent remission.

Shang-Ying Tsai1, Hsin-Chien Lee, Chiao-Chicy Chen, Chao-Hsien Lee.   

Abstract

Clara cell protein (CC16) and transferrin receptor (TfR) have been reported as possible biological markers for major depression and schizophrenia. However, the alternations of plasma TfR and CC16 levels and the influences of numerous clinical variables on them during bipolar mania are not sufficiently described. We investigated the immune function of 36 bipolar I, manic (DSM-IV) patients with Young Mania Rating Scale (YMRS) scores > or =26 as well as during the subsequent remission (YMRS < or =12) and age- and sex- matched healthy controls. The plasma TfR levels were increased during acute mania along with subsequent remission and were independent of medication status, individual variations, clinical and erythrocyte variables. Among inflammatory parameters and haematological variables, the plasma TfR levels merely had significant and negative relationship with the percentage of monocyte in circulating leukocyte counts despite of elevated plasma soluble interleukin-2 receptors levels during bipolar mania. The plasma levels of CC16 of bipolar patients did not significantly alter during acute mania, whereas smoking, body mass index, and co-existing psychotic features collectively contributed 42% of the plasma levels of CC16. We provide additional evidence to indicate the pathophysiological role of the immune systems in affective disorders. It is suggested that the elevation of plasma TfR levels might be a trait phenomenon in bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12650742     DOI: 10.1016/s0022-3956(02)00103-6

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  4 in total

1.  A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Authors:  D R Goldsmith; M H Rapaport; B J Miller
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

Review 2.  Immune and Neuroendocrine Mechanisms of Stress Vulnerability and Resilience.

Authors:  Caroline Ménard; Madeline L Pfau; Georgia E Hodes; Scott J Russo
Journal:  Neuropsychopharmacology       Date:  2016-06-13       Impact factor: 7.853

3.  Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders.

Authors:  S Hossein Fatemi; Teri J Reutiman; Timothy D Folsom; Hao Huang; Kenichi Oishi; Susumu Mori; Donald F Smee; David A Pearce; Christine Winter; Reinhard Sohr; Georg Juckel
Journal:  Schizophr Res       Date:  2008-01-09       Impact factor: 4.939

Review 4.  Potential Candidates for Biomarkers in Bipolar Disorder: A Proteomic Approach through Systems Biology.

Authors:  Paola Rampelotto Ziani; Jacson Gabriel Feiten; Jéferson Ferraz Goularte; Rafael Colombo; Bárbara Antqueviezc; Luiza Paul Géa; Adriane Ribeiro Rosa
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-05-31       Impact factor: 3.731

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.